Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
The Porcine Reproductive and Respiratory Syndrome (PRRS) chimeric virus live vaccine (PC strain) is a veterinary biologic developed by Youbang Pharmaceutical. It is a live-attenuated vaccine based on a chimeric virus construct designed to elicit protective immunity against Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) in swine. PRRS is a highly contagious viral disease that causes significant economic losses in the global pork industry due to reproductive failure in breeding stock and respiratory illness in pigs of all ages. The PC strain is specifically engineered to provide broad protection while maintaining a high safety profile. This vaccine is approved for commercial use in China.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Porcine reproductive and respiratory syndrome chimeric virus live vaccine (PC strain).